Medicus Pharma CEO's firm to buy 436K shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Raza Bokhari reported acquisition or exercise transactions in this Form 4 filing. Medicus Pharma Ltd. (MDCX) reports that RBx Capital, LP, an entity controlled by Chief Executive Officer, director and 10% owner Raza Bokhari, entered a subscription agreement to purchase 436,046 common shares at $1.72 per share in a private placement on November 13, 2026. RBx Capital reported 451,909 common shares following the transaction. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares, no par value F1, F2 | 436,046 | $1.72 | $750K |
Footnotes (2)
- F1. On November 13, 2026, RBx Capital, LP, an entity controlled by Dr. Raza Bokhari, entered into a subscription agreement with the Issuer, pursuant to which RBx Capital, LP agreed to purchase 436,046 common shares, no par value, at a purchase price of $1.72 per share in a private placement in which other investors also participated under separate subscription agreements.
- F2. Held by RBx Capital, LP, an entity controlled by Dr. Raza Bokhari. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Key Figures
Key Terms
private placement financial
subscription agreement financial
pecuniary interest financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.